product summary
Loading...
company name :
R&D Systems
product type :
other
product name :
Human Semaphorin 4D/CD100 (NP_006369) VersaClone cDNA
catalog :
RDC1549
quantity :
10 ug
price :
643 USD
more info or order :
product information
master code :
RDC1549
SKU :
RDC1549
product name :
Human Semaphorin 4D/CD100 (NP_006369) VersaClone cDNA
unit size :
10 ug
description :
R&D Systems Human Semaphorin 4D/CD100 (NP_006369) VersaClone cDNA clone contains the complete ORF for Semaphorin 4D/CD100, along with a Kozak consensus sequence for optimal translation initiation. The gene insert is flanked with convenient multiple cloning sites which can be used to easily cut and transfer the gene cassette into your desired expression vector. The Semaphorin 4D/CD100 insert is sequence verified and the entire plasmid DNA and insert translated sequences are provided.
target :
Semaphorin 4D/CD100
category :
cDNA Clones
species :
Human
gene symbol :
SEMA4D
accessionNumbers :
NP_006369
USD :
643 USD
alt names :
A8, BB18, CD100, CD100 antigen, CD100M-sema-G, coll-4, FLJ33485, FLJ34282, FLJ39737, FLJ46484, immunoglobulin domain (Ig), transmembrane domain (TM) and shortcytoplasmic domain, 4D, MGC169138, MGC169141, M-sema-G, sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and shortcytoplasmic domain, (semaphorin) 4D, SEMA4D, SEMAJ, semaphorin-4D
storage :
Store the unopened product at -20 to -70 ░C. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Do not use past expiration date.
more info or order :
company information

R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.
browse more products
questions and comments